I see they're still aiming to get regulatory approval for Sepsis in early/mid 2022. Early 2022 would be very nice. If this is being conveyed to potential Covid customers it'd be a very strong selling point
Ann: ASX Appendix 4E, page-5
-
- There are more pages in this discussion • 180 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.9¢ |
Change
0.003(11.5%) |
Mkt cap ! $72.20M | |||
| Open | High | Low | Value | Volume |
| 3.1¢ | 3.7¢ | 2.9¢ | $1.433M | 44.19M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 870964 | 2.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 511263 | 4 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| ADO (ASX) Chart |